EMEA Cardiac Valve Market is Expected to Grow at a CAGR of 11.5% by 2023

Pune, India, September, 2017 /MRFR Press Release/- Market Research Future has a half cooked research report on the Europe, Middle East & Africa cardiac valve market.

Market HighlightsHuman heart is consist of four valve. When blood first enters the heart, it passes through the tricuspid valve and then to the pulmonary valve. After returning from the lungs, the blood passes through the mitral valve and exits via the aortic valve as heart valves are one-way valves. 

Furthermore, valve replacement remains the most widely used technique and the proportion of valve repair procedures is increasing in experienced treatment centers. Moreover, developing medical technology and its wide range of applications used in the treatment of various cardiac diseases will fuel the growth of the market over the corresponding period.

However, high cost of the treatment likely to restrain the growth of the market over the assessment period.

The EMEA cardiac valve market is expected to grow at a CAGR of 11.5% during the forecast period 2017-2023.

Taste the market data and market information presented through more than 90 market data tables and figures spread over 80 pages of the project report. Avail the in-depth table of content TOC & market synopsis on “cardiac valve market research report–Europe, the Middle East & Africa forecast till 2023.”

Major Players in Cardiac Valve MarketSome of the key players in the Europe, the Middle East & Africa  market are Medtronic, Edwards Lifesciences Corporation (U.S.), Boston Scientific Corporation (U.S.), St. Jude Medical, Inc. (an Abbott Laboratories Company) (U.S.), LivaNova PLC (U.K.), Symetis SA (Switzerland), Jenavalve Technology, Inc. (Germany), CryoLife, Inc. (U.S.), TTK HealthCare (India), Colibri Heart Valve, LLC (U.S.), Lepu Medical Technology Co., Ltd. (China), and Braile Biomédica (Brazil) 

Regional Analysis

The Middle East & Africa owns the least share of cardiac valve market. However, the Middle East is the major contributor to the market in this region, which is driven by the presence of well-developed economies such as Kuwait and Qatar. On the other hand, due to limited development in the field of medical science and presence of poor countries in Africa, the market is very limited in Africa region.  

SegmentationThe EMEA cardiac valve market is segmented on the basis of types, by diseases, by treatment, and by end users.

On the basis of type, the market is segmented into trans-catheter heart valve, tissue heart valve, mechanical heart valve, and others.

On the basis of disease, the market is segmented into aortic valve replacement, heart valve disease, mitral valve stenosis, and others.

On the basis of treatments, it is segmented: valve replacement, valve repair, and others.

On the basis of end users, the markets segmented into cardiac research institute, hospital & clinics, and others.

Access Complete Report @ https://www.marketresearchfuture.com/reports/emea-cardiac-valve-market-610